CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.

Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.

J Clin Lab Immunol. 1990 Feb;31(2):55-7. Unique Identifier : AIDSLINE MED/92309370
Crocchiolo PR; Lizioli A; Cantaluppi P; Filippi C; D'Agostino F; Cambie G; Panzeri MP; Nardella ML; Infectious Diseases Department, Ospedale Maggiore, Lodi, Italy.

Abstract: In an effort to improve the Walter Reed Staging System (WR), which mainly relies on immune depletion parameters, by introducing viral replication and T-cell activation markers, we examined by p24 antigenaemia and serum neopterin levels (SNL) 72 HIV positive PGL, ARC and AIDS patients (11 of whom classified as WR 2, 21 as WR 3, 16 as WR 5 and 24 as WR 6). While CD4 cell counts, already weakly correlating with the WR itself, did not significantly differ between p24 antigen (p24 AG) positive and negative patients, striking differences between the two groups, especially in PGL patients (p less than 0.0001), were found as far as SNL was concerned. In fact, SNL values, fluctuating around 10 and 30 nmol/l, respectively, in p24 Ag positive and negative patients regardless of their WR allocation, seemed rather to reflect, as global means of any given class, prevalence rate of p24 Ag positivity. We suggest, therefore, to use CD4/SNL ratio (R) for HIV infection and disease staging, as it not only may represent a compromise index between cellular immune depletion and T-cell activation, but also seems to take into account the viral replication component, already shown to be an important predictive marker of disease progression.

Keywords: Acquired Immunodeficiency Syndrome/BLOOD/MICROBIOLOGY Adolescence Adult AIDS-Related Complex/BLOOD/MICROBIOLOGY Biopterin/*ANALOGS & DERIVATIVES/ANALYSIS Comparative Study *CD4-Positive T-Lymphocytes Female Human HIV Core Protein p24/*BLOOD HIV Infections/*BLOOD/MICROBIOLOGY Leukocyte Count Male Viremia/BLOOD JOURNAL ARTICLE
921030
M92A1014

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .